Crossmark

Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population

Crossref DOI link: https://doi.org/10.1186/s12885-019-5312-2

Published Online: 2019-02-01

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gallardo-Alvarado, Lenny N.

Tusié-Luna, María Teresa

Tussié-Luna, María Isabel

Díaz-Chávez, José

Segura, Yayoi X.

Bargallo-Rocha, Enrique

Villarreal, Cynthia

Herrera-Montalvo, Luis A.

Herrera-Medina, Enrique M.

Cantu-de Leon, David F. https://orcid.org/0000-0002-0229-7931
Funding

Funding for this research was provided by:

DGAPA-UNAM (IT-201614)

CONACYT (271928)
License Information

Text and Data Mining valid from 2019-02-01
More Information

Article History

Received: 6 December 2017

Accepted: 21 January 2019

First Online: 1 February 2019

Ethics approval and consent to participate

: This work has been performed in accordance with the Declaration of Helsinki, with the approval of our local IRB (Comité de Etica en Investigación del Instituto Nacional de Cancerología) local approval number 012/052/OMI-CB 805/12. The informed consent was obtained in written format, signed by the patient, two impartial witnesses and the principal investigator. Further information and documentation to support this is available to the Editor on request.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.